This is an exploratory study, the focus of which is to understand the nature of asthma
exacerbations that occur despite open label benralizumab therapy in severe eosinophilic
asthma.
Phase:
Phase 4
Details
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborators:
AstraZeneca Bosch Healthcare Solutions GmbH InHealthcare Queen's University, Belfast University of Glasgow University of Leicester University of Plymouth Vitalograph